Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy. - Wikidata - wikimedia - TriplyDB

Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.

Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.

http://www.wikidata.org/entity/Q39017301

about

Oncolytic viruses as immunotherapy: progress and remaining challenges Radioresistance of Brain Tumors Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer Bidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneity Overcoming therapeutic resistance in glioblastoma: the way forward Accumulation of low-dose BIX01294 promotes metastatic potential of U251 glioblastoma cells HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.Deregulated proliferation and differentiation in brain tumors.β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance Cancer stem cells in glioblastoma UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.The emerging roles of Oct4 in tumor-initiating cells.Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.Temozolomide promotes genomic and phenotypic changes in glioblastoma cells.Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma.Cisplatin induces stemness in ovarian cancer.Suberoylanilide hydroxamic acid represses glioma stem-like cells.Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance.Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer.Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy.Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness.Preclinical investigation of ibrutinib, a Bruton's kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes.A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma Resistance to Cell Death and Its Modulation in Cancer Stem Cells.SOX2 immunity and tissue resident memory in children and young adults with glioma.Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia.Significance of low mTORC1 activity in defining the characteristics of brain tumor stem cells.Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.

P2860

Q26745942-A72DC677-FD89-4EAF-A32D-5CBE590AC819 Q26752579-7317F08E-4E96-4099-AC67-E690A735DADB Q26796793-2FF28A35-2973-4F2A-9CD1-1F2918A4A7BF Q27023599-771985ED-0B30-4D38-BB91-CE96E58A5605 Q28066409-CE51F584-575B-4188-AD86-842F2AAED59E Q29248396-6AB76D71-6321-467C-BBFD-0D85BD4E9B40 Q33597842-B2CB96E5-7681-4F41-94A3-8E63BC333DDC Q33709584-8F3B6C5B-AB31-48B2-8D6E-184B7A7C6CDC Q34364774-B5D39CF4-5F49-4C3A-92BA-2F23D09904C7 Q34457728-2C83503E-620F-4A87-ABA1-125D9CFCB699 Q34518394-939CF317-716A-4EB6-9E98-A1A44153CEAA Q34662363-EED9926F-D680-478C-A4DD-CD6AD46997C9 Q34859989-82B7411C-886E-470A-BFB4-E1B866E30E42 Q34924186-AF24716D-31AA-4B93-816F-8AF679ACACFB Q35376154-CDB57C35-AC4B-45C9-861A-093D20D724A7 Q35657822-916C13E9-5E37-449B-80CF-32C31208576E Q35788935-07FC6C29-DCEA-4559-AC83-8B8342F5BF69 Q35794896-FB7D4A5A-DF26-4F60-BF3D-7A5F21A9946C Q35808894-00E79638-C0B5-4499-9BB2-640B3AC87CF5 Q35828103-FAFE67B1-F7CB-4CDA-BC6F-B891ED59309F Q35829972-4884B020-A7A6-4884-B3D2-A8D4FB94CDFE Q36048547-0AB3517D-812F-4A79-A995-E431FCAD5A2E Q36498067-981F3245-2C75-40FF-ACE7-09DAD35E29C9 Q36545726-01F8F1B3-DCA5-434A-AC47-61AE7A537D08 Q36795940-64F5A73F-F9E4-437F-98F7-42A033C500E8 Q36875981-AC0B6852-6206-4995-BA74-4CB9763A429B Q37274612-3B8E7202-A6DD-463C-BC99-6A8BBEBDC992 Q37327524-C8034C48-7663-434A-B43E-F5320F68445C Q37423898-72A45CE2-8FD8-4DC1-B43E-58833C6ABEB1 Q37441234-50151960-6E17-488E-ACD2-24ADBC5D4F60 Q37598500-D8F32E4D-CC61-442C-BC71-1EB9C75C839C Q37615744-E99B16E4-B348-4241-9805-06ED9CD95940 Q37687644-2847DC55-9C1F-442D-8BBC-602AAA001C72 Q37688468-7810DD85-F029-4F1C-9B92-46937A1359B7 Q37697462-AF2E4AC8-8741-49FB-8C60-C8350F8424D6 Q37708637-1D5977AE-09C3-40A1-B0C6-5843E9D0BFA3 Q38373829-521D67E2-700C-4480-933B-BD262AB324FD Q38682559-8BA3C4D8-6A4A-4277-8E9A-FAFE31F08DAD Q38689740-A140C46E-ADCD-4EDF-BCED-0BA3B481D929 Q38703641-9776A5AE-C6F9-47FC-B5AA-9FCF585BC092

P2860

Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.

http://www.wikidata.org/entity/Q39017301

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Conversion of differentiated c ...... el after primary chemotherapy.

@en

Conversion of differentiated c ...... el after primary chemotherapy.

@nl

type

label

Conversion of differentiated c ...... el after primary chemotherapy.

@en

Conversion of differentiated c ...... el after primary chemotherapy.

@nl

prefLabel

Conversion of differentiated c ...... el after primary chemotherapy.

@en

Conversion of differentiated c ...... el after primary chemotherapy.

@nl

P1433

Q39017301-F08AFA2F-2A61-41D4-B965-3FD632D1F028

P1476

Q39017301-DE14B095-441D-403C-A35A-35A934AE1F02

P2093

Q39017301-431AFF9B-AEB0-414D-9D98-537897A1E108

Q39017301-6B26EA8A-F94A-4D7E-B25D-A4F9A4AADEDB

Q39017301-74045A66-EFC2-4291-A45E-FBD40ECA6492

Q39017301-7B1F7D12-98D5-451F-9A25-16D99417F518

Q39017301-9E05DF8A-31FE-482F-B826-DF868F119DA6

Q39017301-A7C66CC4-BC37-415E-B92C-880B8F7AF9BA

Q39017301-CBC37A14-AFF8-4D83-85C1-4B5DE013AFA9

Q39017301-DDF74CBA-B166-4040-9032-F3798D89FC51

P2860

Q39017301-0C4CAA04-60F7-48E3-8958-B2AE10E7901B

Q39017301-0DD6E308-C463-4592-96B1-3A990524ACC8

Q39017301-131F4327-3BF2-426D-9AD1-5182F71B0378

Q39017301-25F16968-0868-4D44-A547-FF2CE8C14AC7

Q39017301-2809F43A-5CBA-4C9A-A8B4-2B4A64D89810

Q39017301-2A0C48A1-0AC2-4284-97BE-56FE69CF6897

Q39017301-2C797A8C-D228-465C-B5EA-97C69CA5F356

Q39017301-4A66B650-70F3-46C7-B883-DC99423E2688

Q39017301-4B7ABE41-0C29-4BA5-AAE7-76DC0DF6FB35

Q39017301-4D9C8D49-E864-4652-A3A8-D866B6783514

P2888

Q39017301-6FB97AB3-B43C-4F17-9D05-C227A68D2651

P304

Q39017301-A4544230-2C14-47A5-B82C-3A101B419AD2

P31

Q39017301-446319C6-F686-4E18-9200-B00BAB292CC4

P356

Q39017301-FB1EC952-DA9B-41B0-8915-B9DE286F4DDB

P433

Q39017301-B78096DE-87DF-4169-B849-F92FB459D8E2

P478

Q39017301-4A496481-F402-4295-AB0E-D54EEA4F9F2D

P577

Q39017301-4D42F593-3A28-47DC-B3BD-8668CB6D01C9

P5875

Q39017301-789D5BC9-92E1-47A6-9E3C-7DFA203FC11F

P698

Q39017301-95E2F073-F108-4EF3-88C9-404F821E9613

P921

Q39017301-93303FEC-36A0-4083-B046-75AF9DA1B574

P932

Q39017301-6CC6B68A-709B-4A0B-85B5-12FE629103AD

P356

P1433

Cell Death & Differentiation

P1476

Conversion of differentiated c ...... el after primary chemotherapy.

@en

P2093

A L Tobias

http://www.w3.org/2001/XMLSchema#string

A U Ahmed

http://www.w3.org/2001/XMLSchema#string

B Auffinger

http://www.w3.org/2001/XMLSchema#string

D Guo

http://www.w3.org/2001/XMLSchema#string

G Lee

http://www.w3.org/2001/XMLSchema#string

M Dey

http://www.w3.org/2001/XMLSchema#string

M S Lesniak

http://www.w3.org/2001/XMLSchema#string

Y Han

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Identification of human brain tumour initiating cells

Identification of a cancer stem cell in human brain tumors

SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma

Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma

Signatures of mutational processes in human cancer

A restricted cell population propagates glioblastoma growth after chemotherapy

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

P2888

P304

1119-1131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDD.2014.31

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260645831

http://www.w3.org/2001/XMLSchema#string

P698

24608791

http://www.w3.org/2001/XMLSchema#string

P921

P932

4207480

http://www.w3.org/2001/XMLSchema#string